title: Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
abstract: OBJECTIVE
  Our study aims to describe changes in carcinoma in situ (CIS) and invasive cervical carcinoma (ICC) in Korean women diagnosed between 1993 and 2009.
  
  
  METHODS
  All cases of CIS and invasive cervical carcinoma diagnosed from 1993 to 2009 in the Korean National Cancer Incidence database were analyzed. Age-standardized rates (ASRs) and annual percent changes (APCs) in incidence rates were compared according to age and histological type. Additionally, we used Korea National Health and Nutrition Examination Survey (KNHANES) to know the association between screening rate for cervical cancer and incidence rate of cervical cancer.
  
  
  RESULTS
  Between 1993 and 2009, 72,240 cases of ICC were reported in Korea. Total incidence rate of ICC was 14.7 per 100,000 females. ASRs of ICC declined 3.8% per year, from 19.3 per 100,000 in 1993 to 10.5 per 100,000 in 2009. Although the overall incidence rate of adenocarcinoma remained stable, invasive squamous cell carcinoma showed a decreasing trend (APC -4.2%). For women aged 60-79 years, ASRs for squamous cell carcinoma increased from 1993 to 2001, and decreased from 2001 to 2009 (APC: -4.6%). Total 62,300 cases of CIS were diagnosed from 1993 to 2009. Total incidence rate of CIS was 12.2 per 100,000 females. ASRs of CIS increased 5.7% per year, from 7.5 per 100,000 in 1993 to 19.0 per 100,000 in 2009. Adenocarcinoma in situ increased 13.2% per year. There was a strong positive correlation between screening rate for cervical cancer and incidence rate for CIS (p-value = 0.03) whereas screening rate showed a strong negative correlation with incidence rate for squamous ICC (p-value = 0.04).
  
  
  CONCLUSIONS
  The increasing trend in CIS, coupled with a decreasing trend in ICC, suggests the important role of cervix cancer screening. The incidence of adenocarcinoma showed a plateau, but the incidence of adenocarcinoma in situ showed an increasing trend.
authors: Cancer Registration and Statistics Branch, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
authors: Chang-Mo
authors: CM
authors: Oh
authors: Kyu-Won
authors: KW
authors: Jung
authors: Young-Joo
authors: YJ
authors: Won
authors: Aesun
authors: A
authors: Shin
authors: Hyun-Joo
authors: HJ
authors: Kong
authors: Jae Kwan
authors: JK
authors: Jun
authors: Sang-Yoon
authors: SY
authors: Park
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology* / Q000473:pathology; D000328:Adult; D017677:Age Distribution; D000368:Aged; D002278:Carcinoma in Situ / Q000453:epidemiology* / Q000473:pathology; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D018307:Neoplasms, Squamous Cell / Q000453:epidemiology* / Q000473:pathology; D012042:Registries; D056910:Republic of Korea / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000473:pathology; D055815:Young Adult
references: Gynecol Oncol. 2000 Aug;78(2):97-105
references: 10926787
references: Br J Cancer. 2004 Jun 1;90(11):2157-66
references: 15150609
references: Br J Cancer. 1995 Apr;71(4):894-7
references: 7710961
references: J Gynecol Oncol. 2012 Jan;23(1):16-21
references: 22355462
references: Int J Cancer. 2005 Mar 1;113(6):1005-9
references: 15515017
references: Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1833-8
references: 17009979
references: Br J Cancer. 2009 Jul 7;101(1):174-7
references: 19536091
references: Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2191-9
references: 16172231
references: Arch Pathol Lab Med. 2004 Feb;128(2):153-7
references: 14736290
references: Int J Gynecol Cancer. 2001 Jan-Feb;11(1):24-31
references: 11285030
references: Ann Oncol. 2011 Dec;22(12):2675-2686
references: 21471563
references: BMC Cancer. 2010 Apr 16;10:144
references: 20398358
references: J Infect Dis. 2010 Dec 15;202(12):1789-99
references: 21067372
references: PLoS One. 2012;7(4):e35469
references: 22530028
references: Int J Cancer. 2011 Apr 15;128(8):1899-907
references: 20568103
references: Arch Pathol Lab Med. 2009 May;133(5):729-38
references: 19415947
references: Cancer Res Treat. 2012 Mar;44(1):11-24
references: 22500156
references: Stat Med. 2000 Feb 15;19(3):335-51
references: 10649300
references: Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):717-20
references: 18349293
references: J Microbiol Biotechnol. 2008 Apr;18(4):788-94
references: 18467878
references: Br J Cancer. 1999 Sep;81(1):159-66
references: 10487628
references: J Gynecol Oncol. 2009 Mar;20(1):1-7
references: 19471667
references: CMAJ. 2001 Apr 17;164(8):1151-2
references: 11338801
references: Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):677-86
references: 15767349
references: Asian Pac J Cancer Prev. 2011;12(3):725-30
references: 21627372
references: Gynecol Oncol. 2012 Sep;126(3):330-3
references: 22668881
references: Med J Aust. 2006 Nov 6;185(9):482-6
references: 17137451
references: Int J Gynecol Cancer. 2007 May-Jun;17(3):595-600
references: 17300678
references: Int J Cancer. 2007 Feb 15;120(4):885-91
references: 17131323
references: Int J Cancer. 2009 Aug 1;125(3):525-9
references: 19449379
references: Cancer. 2002 Dec 25;96(6):330-7
references: 12478680
references: Int J Cancer. 2003 Jan 20;103(3):413-21
references: 12471626